Scholars Central

Conference abstract

Immunogenicity and protective efficacy of a novel Vi-conjugate vaccine against S. typhi

Authors: Sayan Das

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Salmonella enterica serovar Typhi (S. typhi), a facultative intracellular pathogen with a global morbidity rate of ~10%, is a major threat to public health worldwide. The most widely used Vi-polysaccharide-based vaccine provides inadequate protection to young children where the disease is most prevalent due to the lack of T cell-dependent immunity. Recently approved Vi-conjugate vaccine to a carrier protein (Vi-DT or Vi-TT) reported enhanced protection. To search for a better vaccine, we conjugated Vi-polysaccharide to T2544, an immunogenic outer membrane protein of S. typhi and studied the immunogenicity and protective efficacy of the candidate conjugate vaccine against S. typhi infection in a mouse model. Antibody-dependent cellular cytotoxicity assays showed effective lysis of Salmonella-infected EL4 cells opsonized with antibodies against Vi-T2544 conjugate by NK cells. Candidate conjugate vaccine-specific cytotoxic T lymphocytes (CTLs) were also capable of lysing Salmonella infected EL4 cells. Effector B cells against both rT2544 and Vi-polysaccharide and memory B cells against T2544 were detected in the immunized mice by ELISPOT assays. In addition, Vi-rT2544 induced maturation of dendritic cells (DCs), and antigen-pulsed DCs were capable of inducing T cell proliferation. Both DCs and T cells produced significant amounts of Th1 cytokines that is essential for combating Salmonella infections. Immunization of mice with the conjugate vaccine conferred protection against S. typhi infection, thereby validating the previous observations. In summary, the candidate vaccine may serve as an improved alternative to currently available Vi vaccines, which may also be effective against Vi negative strains.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Sayan Das”